Tricuspid Regurgitation in Congestive "End-Organ" Failure: Outline of an Opportunity

Cardiol Rev. 2024 Jan-Feb;32(1):18-23. doi: 10.1097/CRD.0000000000000455. Epub 2022 Apr 22.

Abstract

Tricuspid regurgitation (TR) is a progressive disease that can be addressed only partially by medical therapy. Progression of TR is associated with worsening end-organ function and worse survival, yet tricuspid valve interventions are usually only performed in advanced stages. Recent evidence suggests a pivotal role for TR and pulsatile venous congestion in the pathophysiology of renal and hepatic dysfunction. This critical knowledge has provided the opportunity to optimally define the appropriate timing of transcatheter tricuspid valve interventions, integrating concurrent or impending functional consequences with severity of TR.

MeSH terms

  • Cardiac Catheterization
  • Heart Valve Prosthesis Implantation*
  • Humans
  • Retrospective Studies
  • Severity of Illness Index
  • Treatment Outcome
  • Tricuspid Valve / surgery
  • Tricuspid Valve Insufficiency* / complications
  • Tricuspid Valve Insufficiency* / surgery